11/29
04:34 pm
cue
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/29
04:30 pm
cue
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/25
08:00 am
cue
Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference
Medium
Report
Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference
11/14
04:17 pm
cue
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
High
Report
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
11/14
04:05 pm
cue
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
High
Report
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
11/14
08:22 am
cue
Cue Biopharma Announces Strategic Organizational Transition [Yahoo! Finance]
Neutral
Report
Cue Biopharma Announces Strategic Organizational Transition [Yahoo! Finance]
11/14
08:00 am
cue
Cue Biopharma Announces Strategic Organizational Transition
Medium
Report
Cue Biopharma Announces Strategic Organizational Transition
11/12
08:00 am
cue
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
High
Report
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
11/8
01:33 pm
cue
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting [Yahoo! Finance]
Medium
Report
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting [Yahoo! Finance]
11/8
01:30 pm
cue
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
Medium
Report
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
10/8
06:45 am
cue
Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89% [Yahoo! Finance]
High
Report
Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89% [Yahoo! Finance]
10/4
03:41 pm
cue
Cue Biopharma stock rallies nearly 40% on upcoming presentations Oct. 04, 2024 3:39 PM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]
Medium
Report
Cue Biopharma stock rallies nearly 40% on upcoming presentations Oct. 04, 2024 3:39 PM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]
10/4
09:00 am
cue
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
High
Report
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting